Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
5 papers
Recent·Most cited
B. M. Murphy, D. M. Jensen, T. E. Arnold…·C. E. Burd
The paper introduces a series of NRAS-mutant melanoma cell lines derived from UV-exposed mice to model human melanoma resistance and therapy responses.
A. Y. Voigt, A. Walter, K. Prieto…·J. Oh
This study shows that the skin microbiome affects the response to anti-PD1 immunotherapy in squamous cell carcinoma by using antibiotic-induced microbiome depletion in mice.
A. Srivastava, C. Tommasi, D. Sessions…·C. S. Lee
This study identifies RET activation driven by MAB21L4-CacyBP interaction as a driver of squamous cell carcinoma and shows RET inhibition as a potential therapeutic strategy.
O. Vera, I. Bok, N. Jasani…·F. A. Karreth
This study shows that MAPK-induced miR-29 suppresses melanoma by targeting MAFG, and its inactivation accelerates tumor development.
A. Aiderus, J. Y. Newberg, L. Guzman-Rojas…·M. B. Mann
This study uses transposon mutagenesis to identify genetic drivers of keratinocyte transformation and cutaneous squamous cell carcinoma progression in vivo, revealing both known and novel genes involved in the disease.